Back to search

Article

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

2020-04-09

Abstract excerpt

<h4>Background: </h4> Costimulatory molecules play significant roles in mounting anti-tumor immune responses, and antibodies targeting these molecules are recognized as promising adjunctive cancer immunotherapies. Here, we aim to conduct a first full-scale exploration of costimulatory molecules from the B7-CD28 and TNF families in patients with lung adenocarcinoma (LUAD) and generated a costimulatory molecule-base...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ac46c5b-7698-5c0a-afd8-9debe78cdcfd
DOI
10.21203/rs.3.rs-21785/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinomaDOI 10.21203/rs.3.rs-21785/v1
Costimulatory Molecule Expression Profile as a Biomarker to Predict Prognosis and Chemotherapy Response for Patients With Small-cell Lung CancerSemantic proximity
Analysis of Clinical Implications and Immune Landscape in Prognostic Model based on Immune Cell Signatures for Lung Adenocarcinoma PatientsSemantic proximity
Identification of a Novel Costimulatory Molecule-Related Signature to Predict Prognostic Risk and Immunotherapy Response in Hepatocellular CarcinomaSemantic proximity
CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung AdenocarcinomaSemantic proximity
IRGS: an immune-related gene classifier for lung adenocarcinoma prognosisSemantic proximity
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaSemantic proximity
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.Semantic proximity
A signature based on costimulatory molecules for the assessment of prognosis and immune characteristics in stomach adenocarcinomaSemantic proximity
Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genesSemantic proximity
Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinomaSemantic proximity
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.Semantic proximity
Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.